← All diseases
Brain and nervous system
Multiple sclerosis (progressive)
Do you want to receive a message when there is new research on Multiple Sclerosis (Progressive)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you see one sentence explaining what was investigated — and you'll be notified as soon as new research on Multiple sclerosis (progressive) is published. View what Premium costs.
Publications and studies (1543)
- Familial multiple sclerosis and association with other autoimmune diseases. (2017/12/19) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis. (2017/12/15) ♡
- Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases. (2017/12/15) ♡
- Epilepsy in multiple sclerosis: A nationwide population-based register study. (2017/12/12) ♡
- Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study. (2017/12/12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS. (2017/12/12) ♡
- Ventilatory efficiency and aerobic capacity in people with multiple sclerosis: A randomized study. (2017/12/12) ♡
- Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trials. (2017/12/08) ♡
- Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI study. (2017/12/08) ♡
- The Turkish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery. (2017/12/06) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis. (2017/12/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical Research on Traditional Chinese Medicine compounds and their preparations for Amyotrophic Lateral Sclerosis. (2017/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis. (2017/12/01) ♡
- Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan. (2017/12/01) ♡
- Should we broaden indications for anti-JCV antibody tests in multiple sclerosis patients? Comments. Anti-JCV antibody index in multiple sclerosis care. (2017/12/01) ♡
- Urinary Excretion of Aluminium and Silicon in Secondary Progressive Multiple Sclerosis. (2017/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Multiple sclerosis: Progressive multifocal leukoencephalopathy risk stratification. (2017/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple sclerosis, a treatable disease. (2017/12/01) ♡
- Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron. (2017/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Alemtuzumab therapy 2017]. (2017/11/30) ♡
- Decreased platelet number in multiple sclerosis during alemtuzumab infusion: a common, transient and clinically silent phenomenon. (2017/11/29) ♡
- Functional Components of Cognitive Impairment in Multiple Sclerosis: A Cross-Sectional Investigation. (2017/11/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Endogenous Opioids in the Etiology and Treatment of Multiple Sclerosis. (2017/11/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Experimental In Vivo Models of Multiple Sclerosis: State of the Art. (2017/11/27) ♡
- Evaluation of neurological changes in secondary progressive multiple sclerosis patients treated with immune modulator MIS416: results from a feasibility study. (2017/11/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Congenital myopathies: clinical phenotypes and new diagnostic tools. (2017/11/15) ♡
- Inhibition of Retrograde Transport Limits Polyomavirus Infection In Vivo. (2017/11/15) ♡
- Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis. (2017/11/15) ♡
- Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments. (2017/11/10) ♡
- Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study. (2017/11/10) ♡
- Limbic system damage in MS: MRI assessment and correlations with clinical testing. (2017/11/09) ♡
- Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals. (2017/11/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis. (2017/11/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date. (2017/11/02) ♡
- Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis. (2017/11/01) ♡
- Interleukin 1 receptor antagonist and 2'-5'-oligoadenylate synthetase-like molecules as novel biomarkers for multiple sclerosis patients in Bahrain. (2017/11/01) ♡
- High dose biotin as treatment for progressive multiple sclerosis. (2017/11/01) ♡
- Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse. (2017/11/01) ♡
- The neutrophil-to-lymphocyte ratio as disease activity marker in multiple sclerosis and optic neuritis. (2017/11/01) ♡
- Epidemiological and clinical characteristics of multiple sclerosis in paediatric population in Slovenia: A descriptive nation-wide study. (2017/11/01) ♡
- Personalized medicine in multiple sclerosis. (2017/11/01) ♡
- Biomarkers in the evolution of multiple sclerosis. (2017/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Facial emotion recognition, theory of mind and empathy in multiple sclerosis]. (2017/11/01) ♡
- Common clinical features of pediatric multiple sclerosis in Pakistan - A report of 15 cases. (2017/11/01) ♡
- The Effect of Emotional Intelligence Training on Self-efficacy in Women with Multiple Sclerosis. (2017/11/01) ♡
- Access to and Use of Clinical Services and Disease-Modifying Therapies by People with Progressive Multiple Sclerosis in the United Kingdom. (2017/11/01) ♡
- Prevention and therapy of JC polyomavirus-mediated progressive multifocal leukoencephalopathy - a realistic possibility? (2017/10/31) ♡
- Quality of life and social support in patients with multiple sclerosis. (2017/10/29) ♡
- Suppression of Inflammatory Demyelinaton and Axon Degeneration through Inhibiting Kv3 Channels. (2017/10/26) ♡
- MerTK-mediated regulation of myelin phagocytosis by macrophages generated from patients with MS. (2017/10/16) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.